NasdaqGS - Delayed Quote • USD
Syros Pharmaceuticals, Inc. (SYRS)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 5:25 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 4,219,578 | 19 |
| Sales | 341,829 | 7 |
| Net Shares Purchased (Sold) | 3,877,749 | 26 |
| Total Insider Shares Held | 283.06k | -- |
| % Net Shares Purchased (Sold) | -107.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROTH DAVID A M.D. Officer | Sale at price 4.95 per share. | Direct | 51,732 | Apr 3, 2024 |
| ROTH DAVID A M.D. Officer | Sale at price 4.98 per share. | Direct | 747 | Apr 2, 2024 |
| SIMONIAN NANCY A Director | -- | Direct | -- | Mar 28, 2024 |
| ROTH DAVID A M.D. Officer | -- | Direct | -- | Mar 28, 2024 |
| STEPHENS KRISTIN Officer | -- | Direct | -- | Mar 28, 2024 |
| CHEE CONLEY Chief Executive Officer | -- | Direct | -- | Mar 28, 2024 |
| HAAS JASON Chief Financial Officer | -- | Direct | -- | Mar 28, 2024 |
| QUIRK GERALD E. Officer | -- | Direct | -- | Mar 27, 2024 |
| AKKARAJU SRINIVAS Director | Purchase at price 5.78 per share. | Indirect | 5,230,767 | Dec 21, 2023 |
| AKKARAJU SRINIVAS Director | Purchase at price 5.78 per share. | Indirect | 5,230,767 | Dec 21, 2023 |
| ROTH DAVID A M.D. Officer | Sale at price 4.95 per share. | Direct | 31,121 | Dec 12, 2023 |
| ROTH DAVID A M.D. Officer | Sale at price 3.95 per share. | Direct | 24,834 | Dec 6, 2023 |
| SIMONIAN NANCY A Chief Executive Officer | -- | Direct | -- | Oct 31, 2023 |
| ROTH DAVID A M.D. Officer | -- | Direct | -- | Oct 31, 2023 |
| STEPHENS KRISTIN Officer | -- | Direct | -- | Oct 31, 2023 |
| CHEE CONLEY Officer | -- | Direct | -- | Oct 31, 2023 |
| HAAS JASON Chief Financial Officer | -- | Direct | -- | Oct 31, 2023 |
| QUIRK GERALD E. Officer | -- | Direct | -- | Oct 11, 2023 |
| AKKARAJU SRINIVAS Director | -- | Direct | -- | Sep 15, 2023 |
| YOUNG RICHARD A Director | -- | Direct | -- | Sep 15, 2023 |
| ALLES MARK J Director | -- | Direct | -- | Sep 15, 2023 |
| AKKARAJU SRINIVAS Director | -- | Direct | -- | Sep 15, 2023 |
| ROTH DAVID A M.D. Officer | Sale at price 3.95 per share. | Direct | 29,025 | Jul 31, 2023 |
| OLSON ERIC R. Officer | Sale at price 3.50 per share. | Direct | 2,412 | Jul 17, 2023 |
| WIRTH PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| FANUCCI MARSHA H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| YOUNG RICHARD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| OH ANDREW M. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| ECKHARDT SUE GAIL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| TYSON TIMOTHY C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| SIMONIAN NANCY A Chief Executive Officer | -- | Direct | -- | Mar 31, 2023 |
| ROTH DAVID A M.D. Officer | -- | Direct | -- | Mar 31, 2023 |
| OLSON ERIC R. Officer | -- | Direct | -- | Mar 31, 2023 |
| STEPHENS KRISTIN Officer | -- | Direct | -- | Mar 31, 2023 |
| CHEE CONLEY Officer | -- | Direct | -- | Mar 31, 2023 |
| HAAS JASON Chief Financial Officer | -- | Direct | -- | Mar 31, 2023 |
| TYSON TIMOTHY C. Director | Purchase at price 5.72 - 6.37 per share. | Direct | 105,955 | Sep 30, 2022 |
| WIRTH PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| AKKARAJU SRINIVAS Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Sep 16, 2022 |
| FANUCCI MARSHA H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| DUNSIRE DEBORAH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| OH ANDREW M. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| AKKARAJU SRINIVAS Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Sep 16, 2022 |
| ECKHARDT SUE GAIL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| TYSON TIMOTHY C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| TYSON TIMOTHY C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
| OLSON ERIC R. Officer | Sale at price 3.47 per share. | Direct | 7,655 | Jan 5, 2022 |
| OLSON ERIC R. Officer | Sale at price 5.55 per share. | Direct | 6,460 | Jul 1, 2021 |
| OLSON ERIC R. Officer | Sale at price 9.47 per share. | Direct | 34,372 | Mar 15, 2021 |
| OLSON ERIC R. Officer | Conversion of Exercise of derivative security at price 1.01 per share. | Direct | 3,664 | Mar 15, 2021 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
32.47
-1.58%
BDTX Black Diamond Therapeutics, Inc.
5.11
+0.99%
TSHA Taysha Gene Therapies, Inc.
2.3000
-2.13%
FGEN FibroGen, Inc.
1.0200
+3.63%
MCRB Seres Therapeutics, Inc.
0.7427
+1.81%
KPTI Karyopharm Therapeutics Inc.
1.0600
-2.75%
GLYC GlycoMimetics, Inc.
1.7100
-7.82%
KURA Kura Oncology, Inc.
19.00
+1.33%
ADAP Adaptimmune Therapeutics plc
1.0600
-1.85%
ALXO ALX Oncology Holdings Inc.
16.87
+4.01%